These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 24518297)
1. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297 [TBL] [Abstract][Full Text] [Related]
2. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon. Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478 [TBL] [Abstract][Full Text] [Related]
3. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71. Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491 [TBL] [Abstract][Full Text] [Related]
4. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach. Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA Virol J; 2015 Sep; 12():140. PubMed ID: 26362430 [TBL] [Abstract][Full Text] [Related]
5. Characterization of malleability and immunological properties of human adenovirus type 3 hexon hypervariable region 1. Zhong T; Li X; Zhou Z; Li T; Tian X; Zhou R Arch Virol; 2012 Sep; 157(9):1709-18. PubMed ID: 22669318 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV. Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982 [TBL] [Abstract][Full Text] [Related]
7. Neutralizing epitopes mapping of human adenovirus type 14 hexon. Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264 [TBL] [Abstract][Full Text] [Related]
8. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice. Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646 [TBL] [Abstract][Full Text] [Related]
9. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector. Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273 [TBL] [Abstract][Full Text] [Related]
10. A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy. Gu L; Krendelchtchikova V; Krendelchtchikov A; Oster RA; Fujihashi K; Matthews QL Virol J; 2014 Jun; 11():112. PubMed ID: 24935650 [TBL] [Abstract][Full Text] [Related]
11. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776 [TBL] [Abstract][Full Text] [Related]
12. Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein. Tian X; Ma Q; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R Viruses; 2015 Oct; 7(10):5632-42. PubMed ID: 26516903 [TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon. Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562 [TBL] [Abstract][Full Text] [Related]
16. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220 [TBL] [Abstract][Full Text] [Related]
17. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129 [TBL] [Abstract][Full Text] [Related]
18. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus. Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118 [TBL] [Abstract][Full Text] [Related]
19. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Li YX; Zhao H; Cao RY; Deng YQ; Han JF; Zhu SY; Ma J; Liu L; Qin ED; Qin CF Virol J; 2014 May; 11():79. PubMed ID: 24885030 [TBL] [Abstract][Full Text] [Related]
20. Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid. Lanzi A; Ben Youssef G; Perricaudet M; Benihoud K Vaccine; 2011 Feb; 29(7):1463-71. PubMed ID: 21184856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]